Search
for
Sort by
Research 751–780 of 1000+
- Hyperandrogenism in Women: Polycystic Ovary Syndrome
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- Exploring Nanotechnology With Traditional Herbal Pharmacology: Nano Carrier-Based Phytochemical Delivery In PCOS Treatment
- Exploring the Causal Relationship and Molecular Mechanisms Between Fasting Insulin and Androgenetic Alopecia: A Mendelian Randomization Study with Bioinformatics Analysis
- Relationship of Serum Prostate Specific Antigen with Hirsutism in Women Having Polycystic Ovary Syndrome Belonging to the Province of Khyber Pakhtunkhwa, Pakistan
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Metabolic Syndrome Prevalence in Psoriasis
- A cross-specialty expert opinion on the management of hair loss in gynaecological and endocrinological disorders in Indian patients
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Redefining hormone resistance in prostate cancer
- Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging
- Clinical profile and lifestyle factors in women with different severities of hirsutism
- A Review and a Brief Explanation of the Poly Cystic Ovarian Syndrome
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Do Pleiotropic Effects of Spironolactone in Women with PCOS make it More Than an Anti-Androgen? Evidence from a Systematic Review and Meta-Analysis
- Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids
- Inhibition of 5-Alpha Reductase Attenuates Cardiac Oxidative Damage in Obese and Aging Male Rats via the Enhancement of Antioxidants and the p53 Protein Suppression
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Gut microbiota variation in admixed Hispanic populations with polyendocrine metabolic ovarian syndrome
- Bilateral ovarian steroid cell tumor in a postmenopausal woman with progressive hyperandrogenism
- Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study
- Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs
- Research gaps in medical treatment of transgender/nonbinary people
- The association between serum ferritin and 25-hydroxyvitamin D and metabolic syndrome in Korean women: the Korea National Health and Nutrition Examination Survey 2010–2012